Jan 10, 2022 / 09:30PM GMT
Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
All right. Good afternoon, everyone. This is Julia Qin from the life science team at JPMorgan, and it's my great pleasure to introduce you to our next presentation today by Sema4. As a reminder, if you have a question, you can submit it through the website.
And with that, let me turn it over to Eric.
Eric E. Schadt - Sema4 Holdings Corp. - Founder, CEO & Director
Awesome. Thank you. Super great to be here today with you to update on Sema4. The slides I'm going to go through were posted on the IR website. So you can gain access to those through that website, and I'll try to be throwing out what slides I'm on. .
Since we're a newest company new, certainly new to the public market, wanted to kind of just start with a kind of a recap on who is Sema4, and we're a patient center of health intelligence company that partners with patients and physicians to generate and aggregate large-scale high dimensional data around patients and to then analyze those data in partnership with
Sema4 Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers